ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors

Biochem Biophys Res Commun. 1997 Apr 28;233(3):765-9. doi: 10.1006/bbrc.1997.6531.

Abstract

VDR regulates gene expression in a ligand-dependent way by binding to cognate enhancer elements of target gene promoters. The ligand-dependent activation function, AF-2, of VDR is thought to require transcriptional co-activators/co-repressors together with basal transcriptional machinery. Using a yeast two hybrid system with VDR, we have isolated a mouse Ca(2+)-binding protein (designated as VAF1) specifically interacting in vivo and in vitro with VDR among nuclear receptors like RAR, RXR, ER and GR. VAF1 is a mouse homologue to human ERC-55, which has recently been shown to interact with human papillomavirus oncogenic protein, E6[1]. Unlike those of many previously identified co-activators, the VDR-VAF1 interaction was ligand-independent. Thus, VAF1 seems a putative VDR-specific cofactor modulating its function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Calcium-Binding Proteins / genetics
  • Calcium-Binding Proteins / metabolism*
  • DNA, Complementary / genetics
  • Humans
  • In Vitro Techniques
  • Mice
  • Molecular Sequence Data
  • Oncogene Proteins, Viral / metabolism*
  • Papillomaviridae / metabolism*
  • Receptors, Calcitriol / metabolism*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae / metabolism
  • Sequence Homology, Amino Acid

Substances

  • Calcium-Binding Proteins
  • DNA, Complementary
  • Oncogene Proteins, Viral
  • RCN2 protein, human
  • Receptors, Calcitriol
  • Recombinant Fusion Proteins
  • VAF1 protein, mouse
  • taipoxin-associated calcium-binding protein 49